Oncotarget

Research Papers:

p27Kip1 regulates alpha-synuclein expression

Edurne Gallastegui, Carla Domuro, Joan Serratosa, Alejandra Larrieux, Laura Sin, Jonatan Martinez, Arnaud Besson, José Manuel Morante-Redolat, Serena Orlando, Rosa Aligue, Isabel Fariñas, María Jesús Pujol, Oriol Bachs _

PDF |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2018; 9:16368-16379. https://doi.org/10.18632/oncotarget.24687

Metrics: PDF 184 views  |   HTML 170 views  |   ?  


Abstract

Edurne Gallastegui1, Carla Domuro1, Joan Serratosa2, Alejandra Larrieux1, Laura Sin1, Jonatan Martinez1, Arnaud Besson3, José Manuel Morante-Redolat4, Serena Orlando1, Rosa Aligue1, Isabel Fariñas4, María Jesús Pujol1 and Oriol Bachs1

1Department of Biomedical Sciences, (CIBERONC), University of Barcelona, Barcelona, Spain

2Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas, Barcelona, Spain

3Cancer Research Center of Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France

4Departamento de Biología Celular, Biología Funcional y Antropología Física, ERI de Biotecnología y Biomedicina, (CIBERNED), Universidad de Valencia, Valencia, Spain

Correspondence to:

Oriol Bachs, email: obachs@ub.edu

Keywords: p27Kip1; p21Cip1; E2F4; alpha synuclein; transcription

Received: September 27, 2017     Accepted: February 27, 2018     Published: March 27, 2018

ABSTRACT

Alpha-synuclein (α-SYN) is the main component of anomalous protein aggregates (Lewy bodies) that play a crucial role in several neurodegenerative diseases (synucleinopathies) like Parkinson’s disease and multiple system atrophy. However, the mechanisms involved in its transcriptional regulation are poorly understood. We investigated here the role of the cyclin-dependent kinase (Cdk) inhibitor and transcriptional regulator p27Kip1 (p27) in the regulation of α-SYN expression. We observed that selective deletion of p27 by CRISPR/Cas9 technology in neural cells resulted in increased levels of α-SYN. Knock-down of the member of the same family p21Cip1 (p21) also led to increased α-SYN levels, indicating that p27 and p21 collaborate in the repression of α-SYN transcription. We demonstrated that this repression is mediated by the transcription factor E2F4 and the member of the retinoblastoma protein family p130 and that it is dependent of Cdk activity. Chromatin immunoprecipitation analysis revealed specific binding sites for p27, p21 and E2F4 in the proximal α-SYN gene promoter. Finally, luciferase assays revealed a direct action of p27, p21 and E2F4 in α-SYN gene expression. Our findings reveal for the first time a negative regulatory mechanism of α-SYN expression, suggesting a putative role for cell cycle regulators in the etiology of synucleinopathies.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 24687